Natixis lowered its holdings in Colgate-Palmolive (NYSE:CL) by 37.1% during the first quarter, HoldingsChannel reports. The firm owned 308,830 shares of the company’s stock after selling 182,500 shares during the period. Natixis’ holdings in Colgate-Palmolive were worth $22,008,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of the business. Elkhorn Investments LLC boosted its stake in Colgate-Palmolive by 4.5% in the fourth quarter. Elkhorn Investments LLC now owns 17,429 shares of the company’s stock worth $1,246,000 after purchasing an additional 743 shares in the last quarter. Gamble Jones Investment Counsel lifted its stake in shares of Colgate-Palmolive by 3.0% during the fourth quarter. Gamble Jones Investment Counsel now owns 26,257 shares of the company’s stock valued at $1,981,000 after acquiring an additional 761 shares during the period. CHICAGO TRUST Co NA lifted its stake in shares of Colgate-Palmolive by 24.5% during the first quarter. CHICAGO TRUST Co NA now owns 4,114 shares of the company’s stock valued at $295,000 after acquiring an additional 810 shares during the period. Salem Investment Counselors Inc. lifted its stake in shares of Colgate-Palmolive by 0.8% during the fourth quarter. Salem Investment Counselors Inc. now owns 101,315 shares of the company’s stock valued at $7,644,000 after acquiring an additional 820 shares during the period. Finally, Global X Management Co. LLC lifted its stake in shares of Colgate-Palmolive by 7.2% during the first quarter. Global X Management Co. LLC now owns 12,371 shares of the company’s stock valued at $887,000 after acquiring an additional 829 shares during the period. 73.23% of the stock is currently owned by institutional investors.
In other Colgate-Palmolive news, Vice Chairman Franck J. Moison sold 80,000 shares of the stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $61.75, for a total value of $4,940,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Daniel B. Marsili sold 19,500 shares of the stock in a transaction dated Monday, April 16th. The stock was sold at an average price of $71.85, for a total value of $1,401,075.00. Following the completion of the sale, the insider now owns 77,935 shares of the company’s stock, valued at $5,599,629.75. The disclosure for this sale can be found here. Insiders sold 142,079 shares of company stock valued at $8,981,683 over the last 90 days. Corporate insiders own 1.02% of the company’s stock.
Several brokerages have recently issued reports on CL. Barclays set a $75.00 price target on Colgate-Palmolive and gave the company a “hold” rating in a research note on Thursday, March 15th. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $72.00 price target on shares of Colgate-Palmolive in a research note on Thursday, May 24th. Argus raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Friday, May 25th. They noted that the move was a valuation call. Stifel Nicolaus reaffirmed a “hold” rating and set a $75.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, April 18th. Finally, Zacks Investment Research raised Colgate-Palmolive from a “sell” rating to a “hold” rating in a research note on Tuesday, April 17th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $76.08.
Colgate-Palmolive opened at $63.31 on Friday, MarketBeat reports. Colgate-Palmolive has a 1-year low of $61.28 and a 1-year high of $77.91. The company has a current ratio of 1.08, a quick ratio of 0.75 and a debt-to-equity ratio of 64.85. The stock has a market capitalization of $55.01 billion, a price-to-earnings ratio of 22.06, a P/E/G ratio of 2.55 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, April 27th. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a return on equity of 1,486.69% and a net margin of 13.30%. The firm had revenue of $4 billion for the quarter, compared to analyst estimates of $4.01 billion. During the same quarter in the prior year, the firm posted $0.67 earnings per share. The company’s quarterly revenue was up 6.4% on a year-over-year basis. research analysts anticipate that Colgate-Palmolive will post 3.15 EPS for the current year.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.